Search results
AbbVie (NYSE:ABBV) Stock Rating Reaffirmed by Cantor Fitzgerald
ETF DAILY NEWS· 5 hours agoAbbVie (NYSE:ABBV – Get Free Report)‘s stock had its “overweight” rating reissued by Cantor Fitzgerald in a note issued to investors on Thursday, Benzinga reports. Cantor ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Alaska Permanent Fund Corp
ETF DAILY NEWS· 17 hours agoAlaska Permanent Fund Corp lowered its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.8% during the first quarter, according to its most recent 13F filing with the Securities ...
Safeguard Financial LLC Takes $235,000 Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 16 hours agoSafeguard Financial LLC acquired a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with ...
AbbVie names Roxanne Austin as new lead independent director By Investing.com
Investing.com· 2 days agoAustin will be taking over from Glenn F. Tilton, who will continue his tenure on the board as an...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks via Yahoo Finance· 18 hours agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use...
Pensionfund Sabic Sells 3,100 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 2 days agoPensionfund Sabic lowered its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 15.7% during the first quarter, according to the company in its most recent Form 13F filing ...
AbbVie Inc. (NYSE:ABBV) Holdings Cut by Carolina Wealth Advisors LLC
ETF DAILY NEWS· 2 days agoCarolina Wealth Advisors LLC decreased its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 5.2% during the 1st quarter, according to its most recent filing ...
As AbbVie Drug Gets FDA Nod, Traders Can Look Up to These Targets
TheStreet.com· 2 days agoAbbVie (ABBV) on Wednesday won Food and Drug Administration approval for a new use for its drug...
AbbVie (NYSE:ABBV) Given New $190.00 Price Target at Piper Sandler
ETF DAILY NEWS· 4 days agoAbbVie (NYSE:ABBV – Get Free Report) had its price objective boosted by research analysts at Piper Sandler from $185.00 to $190.00 in a research note issued on Tuesday, Benzinga ...
239 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Ables Iannone Moore & Associates Inc.
ETF DAILY NEWS· 4 days agoAbles Iannone Moore & Associates Inc. bought a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent disclosure ...